Peripheral Magnetic Stimulation With Balance Training to Decrease Fall Risks in Diabetic Polyneuropathy

Launched by QUEEN SAVANG VADHANA MEMORIAL HOSPITAL, THAILAND · May 29, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help people with diabetic polyneuropathy, a condition that can cause numbness and weakness in the legs and feet, making it harder to balance and increasing the risk of falls. The study will test whether a technique called peripheral magnetic stimulation (PMS) can improve balance when combined with balance training. Participants will stand on a special device that sends gentle magnetic pulses to the soles of their feet while they practice balance exercises. The goal is to see if this treatment can help reduce the risk of falls and improve the overall condition of the participants.

To be eligible for this trial, participants need to have type 2 diabetes with symptoms like numbness or weakness in their legs, and certain balance tests must indicate they are at risk for falls. They should be able to stand or walk for at least five minutes and must not have any severe foot problems or other health issues that could interfere with the study. The trial is not yet recruiting, but it will include adults aged 18 to 90. Participants can expect to engage in balance training sessions while receiving either the magnetic stimulation or a placebo treatment, allowing researchers to compare the effects. This research could lead to new ways to help people with diabetic polyneuropathy stay active and safe.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diabetes mellitus type 2 with any symptoms of distal polyneuropathy, including numbness, paresthesia, dysesthesia, or lower leg weakness.
• • Abnormal 10g monofilament test.
• • Abnormal one-leg stance test (OLST) with eyes open.
• Exclusion Criteria:
• • Chronic foot ulceration.
• • Severe leg or foot pain not controllable with medications or other interventions.
• • Significant foot deformity, including severe pes cavus, severe claw toe, or toe amputation.
• • Body mass index (BMI) over 30 kg/m².
• • Visual acuity less than 20/100 after correction with glasses or contact lenses.
• • Postural instability or coordination disorders resulting from musculoskeletal, vestibular, or central nervous system conditions.
• • Symptoms such as confusion, drowsiness, dizziness, or a high risk of falls due to any disease or recent medication changes within a two-week period.
• • Presence of cardiac pacemaker, knee prosthesis, or metal implants in the lower legs.
• • Inability to walk or stand for at least 5 minutes.
• • Inability to understand, comprehend, or follow instructions required to conduct the study, or to provide informed consent.